Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy

This publication has 37 references indexed in Scilit:

• The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
  Critical Reviews in Oncology/Hematology, 2013
• Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
  Proceedings of the National Academy of Sciences, 2012
• Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
  Cancer Research, 2011
• Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases
  BMC Cancer, 2011
• A phase 2 clinical trial of nab‐paclitaxel in previously treated and chemotherapy‐naive patients with metastatic melanoma
  Cancer, 2009
• Taxol Increases the Amount and T Cell–Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells
  Cancer Research, 2007
• X-Tile
  Clinical Cancer Research, 2004
• Cellular Immunity in Breast Cancer Patients Completing Taxane Treatment
  Clinical Cancer Research, 2004
• Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
  Oncogene, 2003
• Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
  Cell, 1994